fibrocystic


Also found in: Thesaurus, Medical.
Related to fibrocystic: Fibrocystic Disease

fi·bro·cys·tic

 (fī′brō-sĭs′tĭk)
adj.
Characterized by increased fibrosis and cystic spaces, especially in glandular tissue.

fibrocystic

(ˌfaɪbrəʊˈsɪstɪk)
adj
(of a tumour) consisting of fibrous tissue and cysts

fi•bro•cys•tic

(ˌfaɪ broʊˈsɪs tɪk)

adj.
showing or having the increased fibrosis associated with dilated glandular structure.
[1850–55]
Translations

fi·bro·cys·tic

a. fibrocístico-a, fibroquístico-a, de naturaleza fibrosa con degeneración cística;
___ disease of the breastenfermedad ___ de la mama.

fibrocystic

adj fibroquístico
References in periodicals archive ?
Aberrations of normal development and involution (fibrocystic disease), breast pain and nipple discharges are common, and these will be reviewed.
A: Benign lumps in the breast are common and may be of two types: fibrocystic breast disease and fibro adenoma of the breast.
Fibrocystic breast disease creates thickenings and lumps that are generally most pronounced in the week before menstrual periods and regress in between.
When I pointed to the area and reported that I had noticed this tender lump, I was examined and told, "This is fibrocystic disease, don't worry about it".
A Fibrocystic breast disease is a condition where hard, noncancerous lumps form in the breast tissue.
It states she incorrectly diagnosed the lump as fibrocystic disease, failed to refer the patient for further assessment and failed to record adequate details of the examination in the patient's records.
fibrocystic breast disease, cardiac arrhythmias, hypertension or peptic ulcer of stomach (www.positivelycoffee.org / www.coffeescience.org).
A large middle meatal maxillary antrostomy was created at the time of surgery, and a fibrocystic mass was encountered.
"It was found I had the common complaint of fibrocystic breasts.
They are also helpful in controlling hot flashes, menopause, premenstrual syndrome and fibrocystic breast tumors.
Older studies of therapeutic benefits, particularly with respect to fibrocystic breast disease, need to be updated and expanded.
Patients with fibrocystic breast pain (5) reported 85% marked to moderate improvement when compared to 65% in those not receiving serrapeptase.